Acutaas Up 137% in 1 Year; JM Sets ₹3,800 Target
Acutaas Chemicals surged 137% in 1 year; JM Financial sets ₹3,800 target. Major holders include Kotak, SBI, Axis; strong CDMO growth projected by JM Financial. Source: Livemint
Stock news timeline · ACUTAAS
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
Showing 6 of 6 updates · Newest first
Change the keyword or sentiment above, then click Apply.
Acutaas Chemicals surged 137% in 1 year; JM Financial sets ₹3,800 target. Major holders include Kotak, SBI, Axis; strong CDMO growth projected by JM Financial. Source: Livemint
Acutaas Chemicals granted patent for 2,4-Dimethylthiophenol process, valid 20 years from 21 Sept 2017. The patent was developed indigenously, raising the company's total patents to 11. Source: ScoutQuest
Acutaas Chemicals inaugurates a new pilot plant in Surat for R&D and product trials. The facility includes OEB 4 containment for scaling up high-potency intermediates manufacturing. Source: BSE
Acutaas Chemicals' subsidiary Indichem inaugurates a semiconductor materials plant in Gongju, South Korea. Built in 11 months, this venture synergizes Indian chemical synthesis with Korean ultra-purity refining expertise. Source: BSE